WSMGX Mutual Fund

WSMGX Mutual Fund

NAV$26.40
See how much of WSMGX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Dec 31, 2025

Net Assets
$19M
Expense Ratio
1.10%
Dividend Yield (Current)
-
Holdings
414
Inception Date
Jul 15, 1996
Fund Family
Wilshire
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+16.25%
1 Year+26.60%
3 Year+9.59%
5 Year+1.53%
10 Year+8.67%

Asset Allocation

Stocks: 100.00%
See how much of WSMGX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
PEGAPegasystems, Inc.1.60%
LGNDLigand Pharmaceuticals, Inc.1.27%
COGTCogent Biosciences Inc1.19%
FSSFederal Signal Corp1.15%
TARSTarsus Pharmaceuticals Inc1.09%
Top 10 Concentration: 11.29%Report Date: Dec 31, 2025
Download all 414 holdings for WSMGX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$9.61
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

WSMGX Mutual Fund Overview

WSMGX Mutual Fund (Wilshire Small Company Growth Portfolio Fund Investor Class) is managed by Wilshire with $19.1M in net assets. WSMGX expense ratio is 1.10%, holding 414 positions across sectors including Health Care, Information Technology, Industrials. Inception date: 1996-07-15.

WSMGX performance shows a YTD return of 16.25%. The 1-year return is 26.60% and the 5-year return is 1.53%.

WSMGX top holdings include Pegasystems, Inc. (1.6%), Ligand Pharmaceuticals, Inc. (1.3%), Cogent Biosciences Inc (1.2%), Federal Signal Corp (1.1%), Tarsus Pharmaceuticals Inc (1.1%). Go to all WSMGX holdings, WSMGX sectors, or WSMGX dividends.

WSMGX can be compared against other funds. Use WSMGX overlap to find shared positions, or WSMGX vs another fund for a side-by-side view. WSMGX alternatives are available via the screener, along with tax-loss harvesting opportunities.